Individualized dosing with axitinib: rationale and practical guidance.
Future Oncol
; 14(9): 861-875, 2018 Apr.
Article
in En
| MEDLINE
| ID: mdl-29264944
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Vascular Endothelial Growth Factor A
/
Protein Kinase Inhibitors
/
Imidazoles
/
Indazoles
Type of study:
Guideline
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Future Oncol
Year:
2018
Type:
Article
Affiliation country:
Austria